Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress

Thrombosis is a principle cause of cardiovascular disease, the leading cause of morbidity and mortality worldwide; however, the conventional anti-thrombotic approach often leads to bleeding complications despite extensive clinical management and monitoring. In view of the intense crosstalk between i...

Full description

Bibliographic Details
Main Authors: Hao Wu, Ying Wang, Yupeng Zhang, Feng Xu, Jiepeng Chen, Lili Duan, Tingting Zhang, Jian Wang, Fengjiao Zhang
Format: Article
Language:English
Published: Elsevier 2020-05-01
Series:Redox Biology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2213231719315721
id doaj-d8bc414df0ce443582aee3f759f942be
record_format Article
spelling doaj-d8bc414df0ce443582aee3f759f942be2020-11-25T03:26:26ZengElsevierRedox Biology2213-23172020-05-0132Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stressHao Wu0Ying Wang1Yupeng Zhang2Feng Xu3Jiepeng Chen4Lili Duan5Tingting Zhang6Jian Wang7Fengjiao Zhang8Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, ChinaWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, ChinaWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, ChinaWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, ChinaSungen Biotech Co., Ltd, Shantou, 515000, PR ChinaSungen Biotech Co., Ltd, Shantou, 515000, PR ChinaWuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, ChinaKey Laboratory of Structure-Based Drug Design & Discovery, Ministry of Education, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China; Corresponding author.Wuya College of Innovation, Shenyang Pharmaceutical University, Shenyang, Liaoning, 110016, China; Corresponding author.Thrombosis is a principle cause of cardiovascular disease, the leading cause of morbidity and mortality worldwide; however, the conventional anti-thrombotic approach often leads to bleeding complications despite extensive clinical management and monitoring. In view of the intense crosstalk between inflammation and coagulation, plus the contributing role of ROS to both inflammation and coagulation, it is highly desirable to develop safer anti-thrombotic agent with preserved anti-inflammatory and anti-oxidative stress activities. Nattokinase (NK) possesses many beneficial effects on cardiovascular system due to its strong thrombolytic and anticoagulant activities. Herein, we demonstrated that NK not only effectively prevented xylene-induced ear oedema in mice, but also remarkably protected against LPS-induced acute kidney injury in mice through restraining inflammation and oxidative stress, a central player in the initiation and progression of inflammation. Fascinatingly, in line with our in vivo data, NK elicited prominent anti-inflammatory activity in RAW264.7 macrophages via suppressing the LPS-induced TLR4 and NOX2 activation, thereby repressing the corresponding ROS production, MAPKs activation, and NF-κB translocation from the cytoplasm to the nucleus, where it mediates the expression of pro-inflammatory mediators, such as TNF-α, IL-6, NO, and PAI-1 in activated macrophage cells. In particular, consistent with the macrophage studies, NK markedly inhibited serum PAI-1 levels induced by LPS, thereby blocking the deposition of fibrin in the glomeruli of endotoxin-treated animals. In summary, we extended the anti-thrombus mechanism of NK by demonstrating the anti-inflammatory and anti-oxidative stress effects of NK in ameliorating LPS-activated macrophage signaling and protecting against LPS-stimulated AKI as well as glomeruler thrombus in mice, opening a comprehensive anti-thrombus strategy by breaking the vicious cycle between inflammation, oxidative stress and thrombosis.http://www.sciencedirect.com/science/article/pii/S2213231719315721NattokinaseTRL4NOX2InflammationOxidative stressThrombus
collection DOAJ
language English
format Article
sources DOAJ
author Hao Wu
Ying Wang
Yupeng Zhang
Feng Xu
Jiepeng Chen
Lili Duan
Tingting Zhang
Jian Wang
Fengjiao Zhang
spellingShingle Hao Wu
Ying Wang
Yupeng Zhang
Feng Xu
Jiepeng Chen
Lili Duan
Tingting Zhang
Jian Wang
Fengjiao Zhang
Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress
Redox Biology
Nattokinase
TRL4
NOX2
Inflammation
Oxidative stress
Thrombus
author_facet Hao Wu
Ying Wang
Yupeng Zhang
Feng Xu
Jiepeng Chen
Lili Duan
Tingting Zhang
Jian Wang
Fengjiao Zhang
author_sort Hao Wu
title Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress
title_short Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress
title_full Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress
title_fullStr Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress
title_full_unstemmed Breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting LPS-induced inflammation and oxidative stress
title_sort breaking the vicious loop between inflammation, oxidative stress and coagulation, a novel anti-thrombus insight of nattokinase by inhibiting lps-induced inflammation and oxidative stress
publisher Elsevier
series Redox Biology
issn 2213-2317
publishDate 2020-05-01
description Thrombosis is a principle cause of cardiovascular disease, the leading cause of morbidity and mortality worldwide; however, the conventional anti-thrombotic approach often leads to bleeding complications despite extensive clinical management and monitoring. In view of the intense crosstalk between inflammation and coagulation, plus the contributing role of ROS to both inflammation and coagulation, it is highly desirable to develop safer anti-thrombotic agent with preserved anti-inflammatory and anti-oxidative stress activities. Nattokinase (NK) possesses many beneficial effects on cardiovascular system due to its strong thrombolytic and anticoagulant activities. Herein, we demonstrated that NK not only effectively prevented xylene-induced ear oedema in mice, but also remarkably protected against LPS-induced acute kidney injury in mice through restraining inflammation and oxidative stress, a central player in the initiation and progression of inflammation. Fascinatingly, in line with our in vivo data, NK elicited prominent anti-inflammatory activity in RAW264.7 macrophages via suppressing the LPS-induced TLR4 and NOX2 activation, thereby repressing the corresponding ROS production, MAPKs activation, and NF-κB translocation from the cytoplasm to the nucleus, where it mediates the expression of pro-inflammatory mediators, such as TNF-α, IL-6, NO, and PAI-1 in activated macrophage cells. In particular, consistent with the macrophage studies, NK markedly inhibited serum PAI-1 levels induced by LPS, thereby blocking the deposition of fibrin in the glomeruli of endotoxin-treated animals. In summary, we extended the anti-thrombus mechanism of NK by demonstrating the anti-inflammatory and anti-oxidative stress effects of NK in ameliorating LPS-activated macrophage signaling and protecting against LPS-stimulated AKI as well as glomeruler thrombus in mice, opening a comprehensive anti-thrombus strategy by breaking the vicious cycle between inflammation, oxidative stress and thrombosis.
topic Nattokinase
TRL4
NOX2
Inflammation
Oxidative stress
Thrombus
url http://www.sciencedirect.com/science/article/pii/S2213231719315721
work_keys_str_mv AT haowu breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT yingwang breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT yupengzhang breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT fengxu breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT jiepengchen breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT liliduan breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT tingtingzhang breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT jianwang breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
AT fengjiaozhang breakingtheviciousloopbetweeninflammationoxidativestressandcoagulationanovelantithrombusinsightofnattokinasebyinhibitinglpsinducedinflammationandoxidativestress
_version_ 1724592852339523584